The Manila Times

Alpha Tau Medical Receives Japanese Marketing Approval for Alpha DaRT® in Unresectable Locally Advanced or Locally Recurrent Head and Neck Cancer

Approval establishes first clinical authorization outside Israel and initiates post-market surveillance program - ...